We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-3 of 3

Large-scale joint drug venture and MOUs bind North Carolina and China’s Zhejian

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • August 4 2011

North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province

Medicinova and Zhejiang Medicine announce joint venture in China

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • March 10 2011

California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China

Chinese billionaire backs U.S.China biopharma venture

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks

Current Search

Suggested Facets

Author

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy